Lawrence Culp
| This article is a stub. You can help by expanding it. |
Contents
Biographical Information
"Mr. Culp is President and Chief Executive Officer of Danaher, a position he has held since May 2001. Mr. Culp has played a key role in the creation of the Company’s strategic vision, including the evolution of Danaher’s portfolio to a leading science and technology company. Mr. Culp has also played a leadership role in the development of the Danaher Business System, the common operating philosophy and model deployed across Danaher. During Mr. Culp’s tenure, Danaher’s revenues and market capitalization have increased fourfold to greater than $16 billion and $35 billion, respectively.
"Mr. Culp began his Danaher career in 1990 at Veeder-Root where he became President in 1993. He subsequently became a Group Executive and Corporate Officer in 1995 where he had primary leadership responsibility for Danaher's Environmental and Test and Measurement businesses. In 1999 he was appointed Executive Vice President and became Chief Operating Officer in 2000.
"Prior to joining Danaher, Mr. Culp held positions with Accenture. Mr. Culp is a member of the Board of Directors for GlaxoSmithKline, plc., the Board of Visitors and Governors for Washington College and the Board of Trustees for Potomac School. Mr. Culp earned his B.A. from Washington College and his MBA from Harvard Business School."[1]
